Agenda at a GlanceNote: Agenda Subject to Change |
||
Wednesday, October 29, 2025 |
||
| Time | Session | Speaker |
| 3:00-5:00 PM | Registration & Poster Set-Up | |
| 5:00-5:15 PM | Introduction & Greetings from PRF |
Audrey Gordon, Esq. Scott Berns, MD, MPH, FAAP Leslie Gordon, MD, PhD |
| 5:15-5:25 PM | PRF Medical Research Remarks | Leslie Gordon |
| 5:25-6:25 PM | “Coming of Age” Conversations: Young Adults with HGPS as Research Partners | Moderator: Merlin Waldron, USA Kaylee Halko, USA Amber Vandeweert-Wielemans, Belgium Michiel Vandeweert, Belgium Riccardo Zanolli, Italy |
| 6:25-6:35 PM | Musical Kickoff | Francis Collins, MD, PhD |
| 6:35-6:45 PM | Group Photo – All Attendees! | |
| 6:30 PM | Dinner & Collaborative Interaction Time | |
Thursday, October 30, 2025 |
|||
| 7:45 AM-8:00 PM | Registration Desk Open | ||
| 8:00-9:00 AM | Bridging the Bench Mentor Session | ||
| 9:00-9:30 AM | Breakfast | ||
| Current Treatment Trial Outcomes in Progeria Moderator: Mark Kieran, MD, PhD, VP Clinical Development, Day One Biopharmaceuticals | |||
| 9:30-9:50 AM | New Trial: Disease Progression in Progeria | Leslie Gordon, MD, PhD | |
| 9:55-10:15 AM | Phase 2a Progerinin in Clinical Treatment Trial for Progeria | Monica Kleinman, MD Boston Children’s Hospital Harvard Medical School |
|
| 10:20-10:40 AM | Tools for Pivotal Science and Medicine in Progeria: Biomarker Assay Development, Qualification and Reagent Generation | Barbara Natke, PhD Chief Business Officer and Biomarker Lead The Progeria Research Foundation |
|
| 10:45-11:05 AM | Late-Stage Treatment of Aortic Stenosis in HGPS | Ashwin Prakash, MD Pediatric Cardiologist Boston Children’s Hospital |
|
| 11:10-11:30 AM | Break | ||
| 11:35-11:50 AM | Late Breaking Presentation: A novel progerin-producing nonclassic HGPS phenotype: What progeria might look like with effective therapy | Linda Bulmer, MD Sahlgrenska University Hospital Gothenburg, Sweden |
|
| 11:55 AM-12:20 PM | Poster Lightning Round | Poster Presenters | |
| 12:20-1:30 PM | Lunch and Collaborative Interaction Time | ||
| Cardiovascular Disease in HGPS and Aging Moderator: Maria Eriksson, PhD, Professor, Karolinska Institute | |||
| 1:30 -1:50 PM | New Autoptical Pathological findings Revealing HGPS Pathophysiology | Andrea Porzionato, PhD Professor University of Padova |
|
| 1:55-2:15 PM | Single-cell Analysis Reveals the Phenotypic Landscape of Arterial Cells in Progeria | Maria Eriksson, PhD Lara Garcia Merino, MSc |
|
| 2:20-2:40 PM | Evaluation of Coronary Artery and Aortic Calcium in Progeria by Computed Tomography | Sunil Ghelani, MD Attending Cardiologist Boston Children’s Hospital |
|
| 2:45-3:05 PM | Angiopoietin-2: A Potential Therapeutic Target for Vascular Protection in Hutchinson-Gilford Progeria Syndrome | Lizzy Izydore, BS (for Kan Cao, PhD) University of Maryland |
|
| 3:05-3:25 PM | Break | ||
| 3:25-3:45 PM | Bridging the gap: Translating CVpathology to clinical assessments and research study design | Keri Shafer, MD & Sheila Hegde, MD UT Southwestern Medical Center |
|
| 3:50-4:10 PM | Progeria and Vascular Calcification: Diet and Treatments | Ricardo Villa Bellosta, PhD Group Leader, Ramon y Cajal Researcher Center for Research in Molecular Medicine and Chronic Diseases |
|
| 4:15-4:25 PM | Poster Elevation – LRRK2 Knockdown Rescues Progerin-Induced Premature Aging | Lukas Mann Institute of Molecular Biology Mainz, Germany |
|
| 4:25-4:35 PM | Poster Elevation – National Interview Survey for Patients with Hutchinson-Gilford Progeria Syndrome and Progeroid Laminopathies and Their Families in Japan | Yuko Okawa, MD Oita University, Japan |
|
| 4:35 -5:30 PM | Break Adjourn Until Poster Session & Dinner | ||
| 5:30-6:30 PM | Poster Session Part 1 | Even Numbered Posters | |
| 6:00-7:00 PM | Dinner and Collaborative Interaction Time | ||
| 7:00-8:00 PM | Poster Session Part 2 | Odd Numbered Posters | |
Friday, October 31, 2025 |
|||
| 7:30 AM-2:00 PM | Registration Desk Open | ||
| 7:30-8:30 AM | Breakfast & Networking | ||
| Progeria Treatment Discovery for a Healthy Future Moderator: Leslie Gordon | |||
| 8:30-8:50 AM | AI-driven Therapeutic Antisense Oligonucleotide for HGPS | Ning Shen, PhD Professor Liangzhu Laboratory, Zhejiang University School of Medicine |
|
| 8:55-9:15 AM | Development of Gene Silencing (RNAi) and Gene Editing Therapeutics for Hutchinson-Gilford Progeria Syndrome (HGPS) | Nizar Saad, PhD Abigail Wexner Research Institute, Nationwide Children’s Hospital |
|
| 9:20-9:45 AM | Mini Plenary: Cutting Edge Translational Gene Therapy | David Liu, PhD Thomas Dudley Cabot Professor of the Natural Sciences Howard Hughes Medical Institute Investigator Harvard University Broad Institute |
|
| 9:50-10:10 AM | ProSPER: PROgeria Streamlined Platform Gene Editing for Rare Diseases | David Liu Francis Collins Leslie Gordon Meirui An, PhD, Broad Institute Mike Erdos, PhD, NHGRI |
|
| 10:15-10:35 AM | First-Generation PROTACs for Improving Progeria Phenotype | Silvia Ortega Gutierrez, PhD Professor Universidad Complutense de Madrid |
|
| 10:35-10:55 AM | Break | ||
| Endocrine and GI Disease in Progeria Moderator: Vicente Andrés, PhD, Professor, Centro Nacional de Investigaciones Cardiovasculares Carlos III | |||
| 10:55-11:15 AM | Lipodistrophy and Cardiovascular Pathology in HGPS | Vicente Andrés | |
| 11:20-11:40 AM | Unraveling Accelerated Intestinal Ageing in HGPS Physiopathology: An Integrative Approach | Laurence Arbibe, MD, PhD Director INSERM Institut Necker Enfants Malades |
|
| 11:45-12:05 PM | Targeting Inflammation to Ameliorate HGPS Pathologies | Susana Gonzalo, PhD Professor St. Louis University School of Medicine |
|
| 12:15-1:00 PM | Workshop Summary Session All Hands Discussion | Leslie Gordon and Francis Collins | |
2025 PRF International Scientific Workshop Scientific Committee
Leslie B. Gordon, MD, PhD (Chair) – Medical Director, The Progeria Research Foundation; Professor of Pediatrics, Hasbro Children’s Hospital, Boston Children’s Hospital, and Harvard Medical School
Vicente Andres, PhD – Professor, Centro Nacional de Investigaciones Cardiovasculares Carlos III
Maria Eriksson, PhD – Professor, Karolinska Institute
Mark Kieran, MD, PhD – VP Clinical Development, Day One Biopharmaceuticals
2025 PRF International Scientific Workshop Planning Committee
Leslie B. Gordon, MD, PhD (Chair) – Medical Director, The Progeria Research Foundation; Professor of Pediatrics, Hasbro Children’s Hospital, Boston Children’s Hospital, and Harvard Medical School
Audrey Gordon, Esq – President and Executive Director, The Progeria Research Foundation
Gina Incrovato – Director of Operations, The Progeria Research Foundation
Darrien Marazzo – Clinical Trial Coordinator, The Progeria Research Foundation
Karen Gordon Betournay– Social Media and Website Coordinator, The Progeria Research Foundation
Elizabeth Maynard – Elizabeth Maynard, CMP, Meeting Planner, Etre Partners
